103177-37-3 Pranlukast
| 상품명칭 |
Pranlukast |
| 영문 이름 |
Pranlukast; N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide; PLST; N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide; Pranlukast hemihydrate crude; N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide; 4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran |
| 분자식 |
C27H23N5O4 |
| 분자량 |
481.5026 |
| InChI |
InChI=1/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32) |
| cas번호 |
103177-37-3 |
| EC번호 |
201-616-4 |
| 분자 구조 |
|
| 밀도 |
1.374g/cm3 |
| 굴절 지수 |
1.68 |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
